Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1774857 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $6.42Day −4.04%Mkt cap $140M1Y −52.7%Off 52W high −64.2%Vol (1Y) 126.8%
Daily closing price, split-adjusted to the current basis; 1.4y shown of 354 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.0% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−3.07% |
| Top-10 13F concentration86.6% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$69.9M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−51.1% |
| 1Y−52.7% |
| Since incept. (ann.)−42.4% |
Total return through 2026-07-28 · series begins 2025-02-13. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)126.8% |
| Ann. volatility (3Y)124.4% |
| Sharpe (1Y)0.08 |
| Sharpe (3Y)0.21 |
| Max drawdown (1Y)−80.0% |
| Max drawdown (3Y)−80.0% |
| Beta (3Y vs SPY)3.91 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Decheng Capital LLC | 3.9M | $15M | 17.96% | +0.0% |
| CITADEL ADVISORS LLC | 1.2M | $5M | 5.70% | −3.6% |
| Laurion Capital Management LP | 1.0M | $4M | 4.74% | +1.9% |
| BlackRock, Inc. | 792,571 | $3M | 3.63% | +1.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 554,101 | $2M | 2.54% | new |
| Tetragon Partners GP Ltd | 316,621 | $1M | 1.45% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 309,449 | $1M | 1.42% | +3.9% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300,000 | $1M | 1.38% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.99 | — | $0 | — |
| 2025-09-30 | 2025-11-13 | −$0.75 | — | — | — |
| 2025-06-30 | 2025-08-13 | −$0.66 | — | — | — |
| 2025-03-31 | 2025-05-14 | −$0.71 | — | $0 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
